GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Cortex Pharmaceuticals, Inc. (COR) [hlAlert]

Rating:
Sell COR
down 30.09 %

Cortex Pharmaceuticals, Inc. (COR) downgraded to Sell by Cantor Fitzgerald

Posted on: Friday,  Apr 5, 2013  8:25 AM ET by Cantor Fitzgerald

Cantor Fitzgerald rated Sell Cortex Pharmaceuticals, Inc. (NYSE: COR) on 04/05/2013, when the stock price was $34.05. Since
then, Cortex Pharmaceuticals, Inc. has gained 43.05% as of 01/13/2016's recent price of $48.71.
If you would have followed this Cantor Fitzgerald's recommendation on COR, you would have lost 30.09% of your investment in 1013 days.

Cortex Pharmaceuticals, Inc. (Cortex) focuses on developing small molecule compounds that positively modulate AMPA-type glutamate receptors, a complex of proteins involved in the communication between nerve cells in the mammalian brain. These compounds, termed AMPAKINE compounds, enhance the activity of the AMPA receptor. The Company designs and develops these molecules as pharmaceuticals intended for the treatment of neurological and psychiatric diseases, and disorders that are known, or thought, to involve depressed functioning of pathways in the brain that use glutamate as a neurotransmitter. The Company?s clinical compound, CX717 is in Phase II clinical development. Diseases, such as alzheimer?s disease, mild cognitive impairment (MCI), attention deficit hyperactivity disorder (ADHD), schizophrenia, depression, respiratory depression caused by opiate analgesics, and possibly sleep apnea may benefit from treatment with AMPAKINE drugs.

Cantor U.S. Equity Research provides timely and insightful opinions on select stocks. We look at key drivers of the stock price, including company and industry fundamentals, capital markets influences and overall economic trends to provide critical and in-depth analysis. Our focus is on small and mid-cap companies in the following sectors: * Marine Transportation * Life Sciences * Clean Technology & Energy Efficiency * Real Estate * Communications Technology * Internet * Enterprise Software
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
4/5/2013 8:25 AM Sell
None
34.05
as of 12/13/2013
1 Week up  1.92 %
1 Month up  6.74 %
3 Months up  9.81 %
1 YTD up  14.77 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/5/2012 8:25 AM Hold
None
25.82 28.50
8/23/2012 8:25 AM Hold
None
26.22 28.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy